Featured Research

from universities, journals, and other organizations

Mammography reduces mortality from breast cancer in ages 40–49 years, Swedish study finds

Date:
September 29, 2010
Source:
Umeĺ University
Summary:
Mammography examinations of women aged 40–49 reduce breast cancer mortality by 29%, a statistically significant reduction, according to a national study in Sweden.

Mammography examinations of women aged 40-49 reduce breast cancer mortality by 29%, a statistically significant reduction. This is shown in the Umeĺ University-directed national SCRY Study in Sweden, which is the largest study of its kind ever performed anywhere in the world.

Related Articles


X-ray examination of all women's breasts with the aim of discovering breast cancer, so-called mammography screening, saves the lives of many women each year in that tumors are found early and can therefore be treated early. However, a lower age limit for mammography screening is necessary, as younger women run a lower risk of developing breast cancer, which means that more women would have to undergo mammography in order to save the corresponding number of lives. What's more, mammography works less well in younger women.

The SCRY Study (mammography SCReening of Young women) compares breast cancer mortality between a study group consisting of those counties/municipalities that have invited the age group and a control group consisting of areas that have only invited women aged 50 and older. Only deaths caused by breast cancer in the ages of 40-49 were counted. The average follow-up period was 16 years for both the study group and the control group.The study is the largest ever undertaken for the 40-49 age group in the world. Data from the cancer registry and the cause of death registry have been used. Further, individual data from screening centers throughout Sweden have been gathered, making it possible to study the effect both on women who were offered mammography and on women who actually participated.

The study covers the entire country. It comprises 803 breast cancer deaths over 7.3 million person years in the study group (which underwent mammography) and 1,238 breast cancer deaths over 8.8 million person years in the control group. The mean number of women aged 40-49 years in Sweden during the study period was 600,000. The study shows that breast cancer mortality was 26% lower for those who were invited to mammography screening compared with those who were not. Those who actually participated in mammography screening had a 29% lower breast cancer mortality rate than those who were not invited to screening. The findings are statistically significant.

A comparison between the group that underwent mammography and the control group that was undertaken for a period before screening started uncovered no statistically significant difference in breast cancer mortality. Breast cancer care in Sweden has moreover been further standardized since that time, not least as a result of care programs and national guidelines. This indicates that the difference in breast cancer mortality is a result of access to mammography screening among 40-49-year-olds.

There is a consensus today that mammography screening for the 50-69-year age group reduces breast cancer mortality. Calling in women aged 40-49 years for mammography screening, on the other hand, has been controversial and much debated since the 1980s, when mammography screening began. Few studies have been able to show any significant effect on mortality in the age group. At the same time, few studies have been designed to study the age group in particular. The Swedish National Board of Health and Welfare recommends screening for the entire age interval of 40-74 years, whereas EU guidelines do not include 40-49-year-olds in their recommendations. In the U.S., the U.S. Preventive Services Task Force (USPSTF) recently changed its recommendations not to include the 40-49 age group.

Originally the Swedish National Board of Health and Welfare recommended that women aged 40-69 years should be called in for screening. Soon after, these recommendations were changed to focus on women between the ages of 50 and 74. As a result, for a long period roughly half of Swedish counties and municipalities have called in 40-49-year-olds for screening, while about half have chosen to call in only women aged 50 and over.


Story Source:

The above story is based on materials provided by Umeĺ University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Barbro Numan Hellquist, Stephen W. Duffy, Shahin Abdsaleh, Lena Björneld, Pál Bordás, László Tabár, Bedrich Viták, Sophia Zackrisson, Lennarth Nyström, Hĺkan Jonsson. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years. Cancer, 2010; DOI: 10.1002/cncr.25650

Cite This Page:

Umeĺ University. "Mammography reduces mortality from breast cancer in ages 40–49 years, Swedish study finds." ScienceDaily. ScienceDaily, 29 September 2010. <www.sciencedaily.com/releases/2010/09/100929142007.htm>.
Umeĺ University. (2010, September 29). Mammography reduces mortality from breast cancer in ages 40–49 years, Swedish study finds. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2010/09/100929142007.htm
Umeĺ University. "Mammography reduces mortality from breast cancer in ages 40–49 years, Swedish study finds." ScienceDaily. www.sciencedaily.com/releases/2010/09/100929142007.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) — The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) — The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) — New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) — Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins